France’s Juisci, a HealthTech startup that transforms the way in which healthcare professionals devour scientific information, has secured €5.5 million in Seed funding in an effort to increase R&D, scale its group, and speed up worldwide enlargement, with a robust give attention to the U.S. market.
The spherical was led by Large Pi Ventures, with participation from Ring Capital, Bpifrance, and strategic enterprise angels.
“Docs don’t want extra info – they want fast, reliable entry to science. Juisci offers them again time and confidence, whereas enabling organizations to unlock the total worth of scientific information,” stated Robin Roumengas, Co-founder & CEO of Juisci.
Based in 2021 by Robin Roumengas and Dr David Luu, Juisci is a SaaS platform that democratises entry to scientific information via proprietary AI and a mobile-first expertise. Its mission is to assist healthcare professionals save time, struggle misinformation, and leverage science to advance medical progress.
At present, Juisci counts 200,000+ customers in 60 nations and 10 languages, and reportedly works with main pharmaceutical corporations, MedTech companies, shopper healthcare gamers, animal well being leaders, hospitals, and scientific societies.
“Juisci transforms a large quantity of scientific information into actionable, dynamic insights for healthcare professionals. We imagine it would change into an indispensable ally to the medical group worldwide,” stated Man Krief, Companion at Large Pi Ventures.
Medical information is exploding – doubling each 73 days. For medical doctors and healthcare organisations, the flood of complicated publications is almost not possible to maintain up with. Juisci goals to deal with this problem with the primary AI educated particularly on scientific literature, reportedly turning huge volumes of analysis into clear, dependable, and fascinating information delivered via an intuitive cell app.
The platform supplies digestible summaries, article suggestions, movies, podcasts, and infographics, serving to over 200,000 healthcare professionals in 60 nations save as much as 8 hours per week whereas staying on prime of the newest analysis.
In simply 4 years, Juisci has received over 30 main purchasers together with Sanofi, UCB, Takeda, bioMérieux, Johnson & Johnson, Air Liquide, L’Oréal, Opella, Royal Canin, in addition to hospitals and scientific societies such because the Nationwide Academy of Surgical procedure, Dijon College Hospital, and the European Society of Radiology.
